270
Views
66
CrossRef citations to date
0
Altmetric
Research Article

Body distribution of polysorbate‐80 and doxorubicin-loaded [14C]poly(butyl cyanoacrylate) nanoparticles after i.v. administration in rats

, &
Pages 535-542 | Received 08 Jun 2005, Accepted 02 Aug 2005, Published online: 08 Oct 2008
 

Abstract

Previously it was shown that poly(butyl cyanoacrylate) (PBCA) nanoparticles coated with polysorbate 80 are able to cross the blood-brain barrier (BBB) after i.v. administration. The objective of the present study was to investigate the influence of polysorbate 80 and doxorubicin-loading on the body distribution in rats. The biodistribution profile and brain concentration of 14C-radiolabeled PBCA nanoparticles, polysorbate 80 coated 14C-PBCA nanoparticles, and doxorubicin-loaded 14C-PBCA nanoparticles were determined by radioactivity counting after i.v. administration in rats. The 14C-PBCA nanoparticles showed a significant accumulation in the organs of the reticuloendothelial system (RES). Polysorbate 80 coating of the 14C-PBCA nanoparticles decreased this accumulation to about 40% after 1 h post injection. The brain concentration was increased about 2-fold after polysorbate 80-coating at this time point. The presence of doxorubicin in this preparation, however, decreased the brain concentration to levels similar to uncoated particles, probably caused by the positive charge of this compound. After longer time periods after injection the differences between the three preparations decreased.

Abbreviations
BBB=

blood-brain barrier

CNS=

central nervous system

RES=

reticuloendothelial system

NP=

Nanoparticles

PBCA=

poly(butyl cyanoacrylate)

DOX=

doxorubicin

PS=

polysorbate 80

Pgp=

P-glycoprotein efflux system

Abbreviations
BBB=

blood-brain barrier

CNS=

central nervous system

RES=

reticuloendothelial system

NP=

Nanoparticles

PBCA=

poly(butyl cyanoacrylate)

DOX=

doxorubicin

PS=

polysorbate 80

Pgp=

P-glycoprotein efflux system

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.